Pharmaron Beijing Co., Ltd.
SZSE:300759.SZ
27.61 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||
| Nettowinst
| 1,581.781 | 1,352.137 | 1,620.077 | 1,146.992 | 530.674 | 339.026 | 227.024 | 176.912 | 73.846 | 20.995 |
| Afschrijvingen & Amortisatie
| 927.171 | 696.18 | 497.92 | 375.162 | 317.667 | 211.695 | 144.634 | 92.883 | 63.69 | 51.259 |
| Uitgestelde Inkomstenbelasting
| -63.631 | -177.175 | -67.529 | 28.444 | -11.523 | 13.663 | 0 | 0 | 2.303 | 5.256 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 177.175 | 67.529 | 62.458 | 11.523 | 0 | 0 | 22.007 | 31.019 | 8.186 |
| Verandering in Werkkapitaal
| 0.035 | -346.465 | 130.039 | 234.586 | -61.12 | 43.072 | 66.692 | -106.763 | 1.359 | -109.216 |
| Vorderingen
| -480.104 | -786.73 | -216.308 | -95.348 | -286.412 | -173.776 | -133.894 | -114.984 | -31.491 | -91.887 |
| Voorraden
| 82.43 | -120.891 | -224.875 | -120.047 | -37.956 | -28.289 | -1.362 | -45.551 | -18.443 | -13.368 |
| Crediteuren
| 461.34 | 78.804 | 114.703 | 421.538 | 8.07 | 231.475 | 17.55 | 8.644 | 48.991 | 0 |
| Overig Werkkapitaal
| -63.631 | 482.352 | 456.519 | 28.444 | 255.178 | 71.361 | 68.055 | -61.211 | 19.802 | -95.848 |
| Overige Niet-Contante Posten
| 308.184 | 440.965 | -189.992 | -199.031 | 151.366 | 143.466 | 113.865 | 72.735 | 78.043 | 35.654 |
| Kasstroom uit Operationele Activiteiten
| 2,753.539 | 2,142.816 | 2,058.044 | 1,648.61 | 938.586 | 737.258 | 552.215 | 235.768 | 216.939 | 12.135 |
| Investeringsactiviteiten: | ||||||||||
| Investeringen in Materiële Vaste Activa
| -2,865.321 | -2,949.861 | -2,092.822 | -1,315.838 | -754.606 | -640.986 | -934.667 | -1,055.489 | -258.323 | -81.939 |
| Netto Overnames
| 0 | -1,021.838 | -1,230.528 | -791.521 | -59.497 | 22.382 | -345.604 | -80.731 | -222.639 | 0 |
| Aankoop van Beleggingen
| -2,113.169 | -2,336.011 | -4,928.177 | -2,635.72 | -693.94 | -95.997 | 0 | -3.27 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 2,670.731 | 4,096.013 | 2,987.89 | 1,390.578 | 491.34 | 0 | 0 | 1,055.898 | 0 | 0 |
| Overige Investeringsactiviteiten
| 960.698 | 3.155 | 5.49 | -18.55 | -28.501 | 22.382 | 0.359 | -1,055.489 | 0.073 | 0.005 |
| Kasstroom uit Investeringsactiviteiten
| -1,347.061 | -2,208.542 | -5,258.147 | -3,371.051 | -1,045.204 | -714.6 | -1,279.911 | -1,139.081 | -480.889 | -81.934 |
| Financieringsactiviteiten: | ||||||||||
| Schuldaflossingen
| 3,611.74 | -248.715 | 4,321.424 | -137.5 | -592.123 | 59.037 | 633.691 | 373.932 | 16.196 | 23.875 |
| Uitgifte van Gewone Aandelen
| 0 | 7.294 | -295.546 | -13.149 | 5,054.514 | 0 | 0 | 881.378 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -0.83 | -393.384 | -284.058 | 13.149 | -5,054.514 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -444.792 | -354.192 | -237.546 | -119.138 | -72.192 | -74.595 | -60.599 | -14.414 | -15.922 | -14.899 |
| Overige Financieringsactiviteiten
| 749.143 | -370.403 | -126.937 | -10.391 | 4,910.195 | 0 | -0.857 | 921.448 | 297.859 | 33.127 |
| Kasstroom uit Financieringsactiviteiten
| 3,915.262 | -1,417.264 | 3,661.395 | -280.178 | 4,245.88 | -15.558 | 572.235 | 1,280.966 | 298.133 | 42.103 |
| Overige Informatie: | ||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 11.434 | 72.993 | -45.516 | -85.666 | -4.279 | 6.534 | -12.881 | 9.304 | 2.577 | 0.9 |
| Netto Kasstroomverandering
| 4,429.402 | -1,409.997 | 415.776 | -2,088.284 | 4,134.983 | 13.634 | -168.342 | 386.956 | 36.759 | -26.796 |
| Kaspositie aan het Einde van de Periode
| 5,789.115 | 1,359.713 | 2,769.709 | 2,353.934 | 4,442.218 | 307.235 | 293.601 | 461.944 | 74.987 | 38.228 |